1. Home
  2. TNGX vs KELYA Comparison

TNGX vs KELYA Comparison

Compare TNGX & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • KELYA
  • Stock Information
  • Founded
  • TNGX 2014
  • KELYA 1946
  • Country
  • TNGX United States
  • KELYA United States
  • Employees
  • TNGX N/A
  • KELYA N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • KELYA Professional Services
  • Sector
  • TNGX Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • TNGX 413.6M
  • KELYA 752.3M
  • IPO Year
  • TNGX N/A
  • KELYA N/A
  • Fundamental
  • Price
  • TNGX $3.13
  • KELYA $13.94
  • Analyst Decision
  • TNGX Strong Buy
  • KELYA Buy
  • Analyst Count
  • TNGX 8
  • KELYA 1
  • Target Price
  • TNGX $13.14
  • KELYA $25.00
  • AVG Volume (30 Days)
  • TNGX 1.4M
  • KELYA 1.2M
  • Earning Date
  • TNGX 11-06-2024
  • KELYA 02-13-2025
  • Dividend Yield
  • TNGX N/A
  • KELYA 2.15%
  • EPS Growth
  • TNGX N/A
  • KELYA 80.11
  • EPS
  • TNGX N/A
  • KELYA 1.16
  • Revenue
  • TNGX $43,383,000.00
  • KELYA $4,372,900,000.00
  • Revenue This Year
  • TNGX $27.73
  • KELYA N/A
  • Revenue Next Year
  • TNGX N/A
  • KELYA $8.21
  • P/E Ratio
  • TNGX N/A
  • KELYA $11.99
  • Revenue Growth
  • TNGX 15.67
  • KELYA N/A
  • 52 Week Low
  • TNGX $2.70
  • KELYA $12.68
  • 52 Week High
  • TNGX $13.01
  • KELYA $25.27
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 42.05
  • KELYA 45.81
  • Support Level
  • TNGX $2.95
  • KELYA $13.00
  • Resistance Level
  • TNGX $3.20
  • KELYA $13.43
  • Average True Range (ATR)
  • TNGX 0.27
  • KELYA 0.50
  • MACD
  • TNGX 0.08
  • KELYA 0.21
  • Stochastic Oscillator
  • TNGX 72.88
  • KELYA 82.35

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: